# Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

> **NCT00601848** · PHASE2 · TERMINATED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 9 (actual)

## Conditions studied

- Lung Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** chemotherapy
- **DRUG:** porfimer sodium
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** spectroscopy
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT00601848
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-12
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Poor accrual and change in standards of care
- **Last updated:** 2020-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601848, "Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00601848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*